fbpx
Revolutionizing Cancer Treatment: The Promising Panacea of mRNA Vaccines Against the Deadly Pancreatic Cancer

Revolutionizing Cancer Treatment: The Promising Panacea of mRNA Vaccines Against the Deadly Pancreatic Cancer

Dr. Vinod Balachandran and his team at Memorial Sloan Kettering Cancer Center pioneered a personalized mRNA vaccine to potentially redefine the prognosis of pancreatic ductal adenocarcinoma (PDAC), a notoriously difficult to treat cancer. The vaccine works by targeting specific neoantigens on pancreatic cancer cells, activating the immune system's T cells against the disease. Out of 19 study participants, 18 custom vaccines were created, and when administered with an immune checkpoint inhibitor, atezolizumab, these activated powerful T cells in half the patients, preventing recurrence for 18 months. In one case, a liver tumor was entirely eradicated. Disparities in immune response post-vaccination among patients remains to be explored. The clinical trial represents a significant breakthrough via mRNA vaccines in cancer treatment.

Full article here: https://lawsuithelpdesk.com/revolutionizing-cancer-treatment-the-promising-panacea-of-mrna-vaccines-against-the-deadly-pancreatic-cancer/

YouTube
LinkedIn
LinkedIn
Share